Antimicrobial Management of Complicated Skin and Soft Tissue Infections in an Era of Emerging Multi-Drug Resistance: Perspectives from 5 Gulf Countries

다국어 초록 (Multilingual Abstract)

The number of complicated skin and soft tissue infections (cSSTIs) in the Arabian Gulf region has risen in recent years, particularly those caused by multi-drug resistant (MDR) pathogens. The high prevalence of diabetes, obesity, and associated cardio-metabolic comorbidities in the region renders medical and surgical management of cSSTI patients with MDR infections challenging. An experienced panel of international and regional cSSTI experts (consensus group on cSSTIs) was convened to discuss clinical considerations for MDR infections from societal, antimicrobial stewardship, and cost perspectives, to develop best practice recommendations. This article discusses antibiotic therapies suitable for treating MDR cSSTIs in patients from the Gulf region and recommends that these should be tailored according to the local bacterial ecology by country and region. The article highlights the need for a comprehensive patient treatment pathway and defined roles of each of the multidisciplinary teams involved with managing patients with MDR cSSTIs. Aligned and inclusive definitions of cSSTIs for clinical and research purposes, thorough and updated epidemiological data on cSSTIs and methicillin-resistant Staphylococcus aureus in the region, clearcut indications of novel agents and comprehensive assessment of comparative data should be factored into decision-making are necessary.

다국어 초록 (Multilingual Abstract)

The number of complicated skin and soft tissue infections (cSSTIs) in the Arabian Gulf region has risen in recent years, particularly those caused by multi-drug resistant (MDR) pathogens. The high prevalence of diabetes, obesity, and associated cardio-metabolic comorbidities in the region renders medical and surgical management of cSSTI patients with MDR infections challenging. An experienced panel of international and regional cSSTI experts (consensus group on cSSTIs) was convened to discuss clinical considerations for MDR infections from societal, antimicrobial stewardship, and cost perspectives, to develop best practice recommendations. This article discusses antibiotic therapies suitable for treating MDR cSSTIs in patients from the Gulf region and recommends that these should be tailored according to the local bacterial ecology by country and region. The article highlights the need for a comprehensive patient treatment pathway and defined roles of each of the multidisciplinary teams involved with managing patients with MDR cSSTIs. Aligned and inclusive definitions of cSSTIs for clinical and research purposes, thorough and updated epidemiological data on cSSTIs and methicillin-resistant Staphylococcus aureus in the region, clear-cut indications of novel agents and comprehensive assessment of comparative data should be factored into decision-making are necessary.

참고문헌 (Reference)

1 Bowler PG, "Wound microbiology and associated approaches to wound management" 14 (14): 244-269, 2001

2 Bassetti M, "When to switch to an oral treatment and/or to discharge a patient with skin and soft tissue infections" 31 (31): 163-169, 2018

3 ANI pharmaceuticals Inc, Minnesota USA, "Vancomycin"

4 Harbarth S, "Update on screening and clinical diagnosis of meticillin-resistant Staphylococcus aureus(MRSA)" 37 (37): 110-117, 2011

5 Werner NL, "Unnecessary use of fluoroquinolone antibiotics in hospitalized patients" 11 : 187-, 2011

6 Harbarth S, "Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients" 299 (299): 1149-1157, 2008

7 Matar MJ, "Treatment patterns, resource utilization, and outcomes among hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections in Lebanon and Saudi Arabia" 10 : 43-48, 2017

8 Jabbour JF, "Treatment of multidrug-resistant Gram-negative skin and soft tissue infections" 33 (33): 146-154, 2020

9 Eckmann C, "Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: Value of linezolid, tigecycline, daptomycin and vancomycin" 15 (15): 554-563, 2010

10 Szumowski JD, "Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic" 51 (51): 423-428, 2007

11 Pfizer, Kent UK, "Tigecycline 50 mg/vial for injection"

12 Brink AJ, "The role of multidrug and extensive-drug resistant Gam-negative bacteria in skin and soft tissue infections" 33 (33): 93-100, 2020

13 Aly M, "The prevalence of antimicrobial resistance in clinical isolates from Gulf Corporation Council countries" 1 (1): 26-, 2012

14 Demling RH, "The increasing problem of wound bacterial burden and infection in acute and chronic soft-tissue wounds caused by methicillin-resistant Staphylococcus aureus" 7 : e8-, 2007

15 Eckmann C, "The importance of source control in the management of severe skin and soft tissue infections" 29 (29): 139-144, 2016

16 Hitam SAS, "The Significant Association between Polymicrobial Diabetic Foot Infection and Its Severity and Outcomes" 26 (26): 107-114, 2019

17 Rhodes A, "Surviving Sepsis Campaign : International Guidelines for Management of Sepsis and Septic Shock : 2016" 43 (43): 304-377, 2017

18 Eagye KJ, "Surgical site infections : Does inadequate antibiotic therapy affect patient outcomes" 10 (10): 323-331, 2009

19 Alfouzan W, "Surgical site infection following cesarean section in a general hospital in Kuwait : Trends and risk factors" 147 : e287-, 2019

20 Basilea Medical Ltd, "Summary of Product Characteristics: Zevtera 500 mg powder for concentrate for solution for infusion" Medicines and Healthcare Products Regulatory Agency

21 Suaya JA, "Skin and soft tissue infections and associated complications among commercially insured patients aged 0-64years with and without diabetes in the U.S" 8 (8): e60057-, 2013

22 Boswihi SS, "Shifts in the Clonal Distribution of Methicillin-Resistant Staphylococcus aureus in Kuwait Hospitals : 1992-2010" 11 (11): e0162744-, 2016

23 Barbier F, "Risk stratification for multidrug-resistant bacteria in patients with skin and soft tissue infection" 33 (33): 137-145, 2020

24 Tran TS, "Risk factors for postcesarean surgical site infection" 95 (95): 367-371, 2000

25 Halilovic J, "Risk factors for clinical failure in patients hospitalized with cellulitis and cutaneous abscess" 65 (65): 128-134, 2012

26 Sreeramoju P, "Recurrent skin and soft tissue infections due to methicillinresistant Staphylococcus aureus requiring operative debridement" 201 (201): 216-220, 2011

27 Mahmood A, "Prevalence of methicillin-resistant Staphylococcus aureus(MRSA)and use of tunneled hemodialysis catheters" 2019 (2019): 86-, 2019

28 Stevens DL, "Practice guidelines for the diagnosis and management of skin and soft tissue infections : 2014 update by the Infectious Diseases Society of America" 59 (59): 147-159, 2014

29 Pfizer, Kent UK, "Piperacillin- Tazobactam IV"

30 Udo EE, "Molecular typing of methicillin-resistant Staphylococcus aureus isolated in a Bahrain hospital" 17 (17): 308-314, 2008

31 El-Mahdy TS, "Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients" 20 (20): 169-173, 2014

32 Alfouzan W, "Molecular Characterization of Methicillin-Resistant Staphylococcus aureus in a Tertiary Care hospital in Kuwait" 9 (9): 18527-, 2019

33 Nair D, "Microbiological and clinical characteristics of sternal wound infections following cardiac surgery in a teaching hospital in Kuwait : A 5-year retrospective study" 1 (1): 30-36, 2019

34 Lee AS, "Methicillin-resistant Staphylococcus aureus" 4 : 18033-, 2018

35 Al Jalaf M, "Methicillin resistant Staphylococcus Aureus in emergency department patients in the United Arab Emirates" 18 (18): 12-, 2018

36 Fish DN, "Meropenem in the treatment of complicated skin and soft tissue infections" 2 (2): 401-415, 2006

37 Pfizer, UK K, "Meropenem 500mg IV"

38 "Menarini Industrie Farmaceutiche, Florence Italy"

39 Howell MD, "Management of Sepsis and Septic Shock" 317 (317): 847-848, 2017

40 Zigmond J, "MRSA infection and colonization rates in Africa and the Middle East : a systematic review and meta-analysis" 170-, 2014

41 Berger A, "Initial treatment failure in patients with complicated skin and skin structure infections" 14 (14): 304-312, 2013

42 Bassetti M, "Influence of age on the clinical efficacy of tigecycline in severely ill patients" 18 : 199-206, 2019

43 Ray GT, "Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: A retrospective population-based study" 13 : 252-, 2013

44 Garcell HG, "Implementation of surveillance systems to determine the burden of communicable diseases in a facility in Qatar" 25 (25): 813-819, 2019

45 International Diabetes Federation, "IDF Diabetes Atlas" International Diabetes Federation 2019

46 Zilberberg MD, "Hospitalizations with healthcare-associated complicated skin and skin structure infections : Impact of inappropriate empiric therapy on outcomes" 5 (5): 535-540, 2010

47 Sulaiman N, "High prevalence of diabetes among migrants in the United Arab Emirates using a cross-sectional survey" 8 (8): 6862-, 2018

48 "Guidance for Industry - Acute Bacterial Skin and Skin Structure Infections:Developing Drugs for Treatment" Centre for Drug Evaluation and Research, Food and Drug Administration

49 Udo EE, "Genotyping of methicillin-resistant Staphylococcus aureus in the Sultan Qaboos University Hospital, Oman reveals the dominance of Panton-Valentine leucocidinnegative ST6-IV/t304 clone" 2 (2): 100-105, 2014

50 Ostojić M, "Genotypic and phenotypic characteristics of Methicillin-resistant Staphylococcus aureus (MRSA) strains, isolated on three different geography locations" 15 (15): 48-56, 2015

51 Talan DA, "Factors associated with decision to hospitalize emergency department patients with skin and soft tissue infection" 16 (16): 89-97, 2015

52 Al Rahmany D, "Exploring bacterial resistance in Northern Oman, a foundation for implementing evidence- based antimicrobial stewardship program" 83 : 77-82, 2019

53 Francois P, "Evaluation of three molecular assays for rapid identification of methicillin-resistant Staphylococcus aureus" 45 (45): 2011-2013, 2007

54 Bassetti M, "European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid" 20 (20): 3-18, 2014

55 Linder KE, "Epidemiology, treatment, and economics of patients presenting to the emergency department for skin and soft tissue infections" 45 (45): 9-15, 2017

56 Balkhair A, "Epidemiology of multi-drug resistant organisms in a teaching hospital in oman: A one-year hospital-based study" 2014 : 157102-, 2014

57 Zilberberg MD, "Epidemiology and outcomes of hospitalizations with complicated skin and skin-structure infections : Implications of healthcare-associated infection risk factors" 30 (30): 1203-1210, 2009

58 Zervos MJ, "Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients" 50 (50): 238-245, 2012

59 Udo EE, "Emergence of Methicillin-Resistant Staphylococcus aureus Belonging to Clonal Complex 15(CC15-MRSA)in Kuwait Hospitals" 13 : 617-626, 2020

60 Pullman J, "Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: A Phase 3, double-blind, randomized study" 72 (72): 3471-3480, 2017

61 Garau J, "Current management of patients hospitalized with complicated skin and soft tissue infections across Europe(2010-2011) : Assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study" 19 (19): E377-E385, 2013

62 Montravers P, "Current guidelines and recommendations for the management of skin and soft tissue infections" 29 (29): 131-138, 2016

63 Theocharidis V, "Current evidence on the role of smoking in plastic surgery elective procedures : A systematic review and meta-analysis" 71 (71): 624-636, 2018

64 Harbarth S, "Control of endemic methicillin-resistant Staphylococcus aureus-recent advances and future challenges" 12 (12): 1154-1162, 2006

65 DiNubile MJ, "Complicated infections of skin and skin structures : when the infection is more than skin deep" 53 (53): ii37-ii50, 2004

66 Alkharsah KR, "Comparative and molecular analysis of MRSA isolates from infection sites and carrier colonization sites" 17 (17): 7-, 2018

67 Nichols RL, "Clinical presentations of soft-tissue infections and surgical site infections" 33 (33): S84-S93, 2001

68 Edelsberg J, "Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections" 29 (29): 160-169, 2008

69 Miller LG, "Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections" 372 (372): 1093-1103, 2015

70 Cardinal Health, Dublin Ireland, "Clindamycin"

71 Pfizer, Cork Ireland, "Ceftaroline fosamil 600mg for infusion"

72 Shankar C, "Bad bug, no test:Tigecycline susceptibility testing challenges and way forward" 37 (37): 91-94, 2019

73 Tognetti L, "Bacterial skin and soft tissue infections: Review of the epidemiology, microbiology, aetiopathogenesis and treatment: A collaboration between dermatologists and infectivologists" 26 (26): 931-941, 2012

74 Ki V, "Bacterial skin and soft tissue infections in adults: A review of their epidemiology, pathogenesis, diagnosis, treatment and site of care" 19 (19): 173-184, 2008

75 Stargardt T, "Attitudes of physicians from 10 European countries on adherence and how treatment modalities in ABSSSI affect adherence : Results from a Delphi survey" 37 (37): 1611-1618, 2018

76 Avila C, "Association of smoking with wound complications after cesarean delivery" 25 (25): 1250-1253, 2012

77 Udo EE, "Antibiotic Resistance Trends in Methicillin-Resistant Staphylococcus aureus Isolated in Kuwait Hospitals : 2011-2015" 26 (26): 485-490, 2017

78 GSK, Dublin Ireland, "Amoxicillin-clavulanic acid"

79 Soriano A, "A costminimization model to evaluate the impact of ceftaroline fosamil for the treatment of complicated skin and soft tissue infections in hospitalized adults in Spain" 21 (21): S231-, 2018

80 Lipsky BA, "A Proposed New Classification of Skin and Soft Tissue Infections Modeled on the Subset of Diabetic Foot Infection" 4 (4): ofw255-, 2017

81 O'Riordan W, "A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin with Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study" 67 (67): 657-666, 2018

82 Sartelli M, "2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections" 13 : 58-, 2018